Muscular Dystrophy, Oculopharyngeal

Explore clinical trials studying Muscular Dystrophy, Oculopharyngeal. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Muscular Dystrophy, Oculopharyngeal trial results

Recruiting

Oral Health, Saliva Viscosity and Composition in Oculo-Pharyngeal Muscular Dystrophy (OPMD)

NCT07118280

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +7 more
Locations: Sheba Medical Center Ramat Gan, Israel

View Trial Details

Recruiting

A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia

NCT06185673

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +7 more
Locations: NYU Langone Health New York, United States

View Trial Details

Recruiting

Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry

NCT07146256

Conditions: Blepharoptosis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deglutition Disorders, +22 more
Locations: Sheba Medical Center Ramat Gan, Israel

View Trial Details

Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

NCT01793168

Conditions: 1p36 Deletion Syndrome, 3-Methylglutaconic Aciduria, Type V, 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome, +698 more
Locations: Sanford Health Sioux Falls, South Dakota, United States

Online Patient Enrollment System Sydney, Australia

View Trial Details

Completed

Screening in Oculopharyngeal Muscular Dystrophy

NCT02877784

Conditions: Articulation Disorders, Communication Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +22 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Completed

Continuation Protocol to Protocol BBCO-001

NCT02328482

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +7 more
Locations: Montreal Neurological Institute, McGill University Montreal, Quebec, Canada

View Trial Details

Completed

Safety Tolerability and Efficacy Study of Cabaletta to Treat Oculopharyngeal Muscular Dystrophy (OPMD) Patients

NCT02015481

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Muscular Diseases, +7 more
Locations: UCLA Los Angeles, California, United States

Tahseen Mozaffar Orange, California, United States

Montreal Neurological Institute, McGill University Montreal, Quebec, Canada

Hadassah medical center Jerusalem, Israel

View Trial Details

Completed

Treatment of Dysphagia in Oculopharyngeal Muscular Dystrophy by Autologous Transplantation of Myoblasts

NCT00773227

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Deglutition Disorders, Digestive System Diseases, +12 more
Locations: Hospital Tenon Paris, France

View Trial Details

Completed

Study of Muscle Abnormalities in Patients With Specific Genetic Mutations

NCT00001871

Conditions: Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +14 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Muscular Dystrophy, Oculopharyngeal

Muscular Dystrophy, Oculopharyngeal trial results

Related conditions